Indications & Dose:
Diabetes mellitus, type 2
DOSE
Adults: Initially 1mg daily adjusted at breakfast according to response. Titration in dose is carried out step wise as follows: 1mg-2mg-3mg-4mg-6mg at the intervals of 1-2 weeks. Normally a single daily dose is sufficient and it should be taken immediately before a substantial breakfast or before the first main meal.
Children: Not recommended.
Note. If changing from other oral hypoglycaemic drugs, the strength and half-life of the previous drug must be taken into account and, if necessary, a washout period of a few days between drugs should be considered to minimise the risk of hypoglycaemia
Contraindications:
Diabetes mellitus, type 1; ketoacidosis .
Side Effects:
Cautions:
Precautions:
Elderly, cardiac disease, severe renal disease, severe Hepatic disease; thyroid disease, adrenal or pituitary insufficiency, debilitated or malnourished patients
Interaction:
Drugs
Anabolic steroids: Enhanced hypoglycemic response
Angiotensin converting enzyme inhibitors: Increased risk of hypolycemia
Antacids: Enhanced rate of absorption
Aspirin: Enhanced hypoglycemic effect
ß-Adrenergic blockers: Alteredresponse to hypoglycemia; prolonged recovery of normoglycemia, hypertension, blockade of tachycardia; may increase blood glucose concentration
Clofibrate: Enhanced effects of oral hypoglycemic drugs
Corticosteroids: Increased blood glucose in diabetic patients
Cyclosporine: Increased cyclosporine levels
Ethanol: Excessive intake may lead to altered glycemic control; “Antabuse” -like reaction may occur
Gemfibrozil: Increased risk of hypoglycemia
H2-receptor antagonists: Enhanced rate of absorption
MAOIs: Excessive hypoglycemia may occur in patients with diabetes
Phenylbutazole: Increases serum concentrations of oral hypoglycemic drugs
Proton pump blockers: Enhanced rate of absorption
Rifampin: Reduced sulfonylurea concentrations
Sulfonamides: Enhanced hypoglycemic effects of sulfonylureas
Thiazide diuretics: Potential increased dosage requirement of antidiabetic drugs
Warnings:
Adverse Effects:
Lactations:
Inappropriate for use during pregnancy due to inadequacy for blood glucose control, potential for prolonged neonatal hypoglycemia, and risk of congenital abnormalities; insulin is the drug of choice for control of blood sugars during pregnancy breast milksecretion, unknown; the potential for neonatal hypoglycemia dictates caution in nursing mothers
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
CNS: Dizziness, drowsiness, headache, paresthesia
EENT: Blurred vision, tinnitus, vertigo
GI: Cholestatic jaundice, constipation, diarrhea, elevated liver function tests, gastralgia, nausea
HEME : Agranulocytosis, aplastic anemia, hemolytic anemia, hepatic Porphyria,leukopenia pancytopenia, thrombocytopenia
METAB: Hypoglycemia, hyponatremia, SIADH
MS: Fatigue, weakness
SKIN: Eczema, erythema, morbilli form or maculopapular eruptions, pruritus, urticaria
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team